Eaton Financial Holdings’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$929K Buy
38,591
+7,251
+23% +$190K 0.26% 66
2026
Q1
$880K Buy
31,340
+212
+0.7% +$5.64K 0.29% 72
2025
Q4
$775K Buy
31,128
+3,166
+11% +$79.8K 0.21% 78
2025
Q3
$712K Buy
27,962
+4,291
+18% +$106K 0.2% 77
2025
Q2
$574K Buy
+23,671
New +$552K 0.18% 77
2024
Q4
Sell
-13,180
Closed -$381K 67
2024
Q3
$381K Buy
+13,180
New +$384K 0.16% 56
2024
Q1
$410K Sell
14,757
-1,581
-10% -$43.9K 0.21% 50
2023
Q4
$470K Sell
16,338
-19,859
-55% -$600K 0.11% 127
2023
Q3
$1.2M Sell
36,197
-2,339
-6% -$82.7K 0.32% 78
2023
Q2
$1.41M Buy
38,536
+206
+0.5% +$8.02K 1.07% 19
2023
Q1
$1.56M Sell
38,330
-779
-2% -$33.6K 1.22% 18
2022
Q4
$2M Buy
+39,109
New +$1.88M 1.71% 13

Other funds holding PFE

Eaton Financial Holdings's PFE Position: Q2 2026 in Review

Eaton Financial Holdings increased its Pfizer (PFE) stake by 23% in Q2 2026, buying an estimated $190K and bringing the position to 38,591 shares worth $929K. The position accounts for 0.26% of the portfolio, ranked #66.

Eaton Financial Holdings first reported a position in PFE in Q4 2022 and has held it in 12 quarters since. The position peaked at $2M in Q4 2022. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Eaton Financial Holdings held 38,591 shares of Pfizer worth $929K as of Q2 2026.
  • Eaton Financial Holdings bought 7,251 Pfizer shares in Q2 2026, an estimated $190K.
  • Pfizer made up 0.26% of Eaton Financial Holdings's portfolio in Q2 2026, its #66 holding.
  • Eaton Financial Holdings first reported a position in Pfizer in Q4 2022 and has held it in 12 quarters since.
  • Eaton Financial Holdings's Pfizer position peaked at $2M in Q4 2022.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Eaton Financial Holdings's 13F filing for Q2 2026, filed 5 Aug 2026.